AVORO CAPITAL ADVISORS LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:18 am Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-3,060,000 (Position Closed) |
Filing |
| 2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 3,060,000 6.700% |
1,595,000 (+108.87%) |
Filing |
| 2022-02-11 10:06 am Sale |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 1,465,000 3.200% |
-885,267 (-37.67%) |
Filing |
| 2021-02-12 08:11 am Purchase |
2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 2,350,267 5.300% |
2,350,267 (New Position) |
Filing |